Literature DB >> 31736117

Comparison of hair manifestations in cardio-facio-cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth.

J Urban1, L Qi2, H Zhao3, I Rybak1, K A Rauen4, M Kiuru1,5.   

Abstract

BACKGROUND: Abnormal hair growth is a defining feature of RASopathies, syndromes caused by germline mutations in the RAS pathway. However, detailed hair manifestations and the mechanisms of altered hair growth in RASopathies are poorly delineated.
OBJECTIVES: To identify distinguishing clinical features and investigate how the RAS pathway influences hair growth by performing a systematic and detailed side-by-side comparison of hair manifestations in cardio-facio-cutaneous syndrome (CFCS) and Costello syndrome (CS), two RASopathies caused by mutations in the downstream and upstream elements of the RAS pathway, respectively.
METHODS: Sixteen individuals with CFCS and 23 individuals with CS were enrolled. Mutation data were recorded. Scalp hair, eyebrows and eyelashes of individuals with CFCS or CS were examined for texture, colour, density and morphology. Scalp hairs were examined by light microscopy.
RESULTS: While both syndromes displayed abnormal hair, striking differences were observed, including darker and thicker scalp hair and sparse eyebrows and eyelashes in CFCS. By contrast, synophrys, trichomegaly and abnormalities of the scalp hair shafts were observed in CS. Possible correlation with straight hair and genotype was observed in CS.
CONCLUSION: The results emphasize the role of the RAS pathway in hair growth, improve accuracy of clinical diagnosis of CFCS and CS and provide a foundation for identification of therapeutic targets.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31736117      PMCID: PMC7050334          DOI: 10.1111/jdv.16082

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  29 in total

Review 1.  Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.

Authors:  Mary Ella M Pierpont; Pilar L Magoulas; Saleh Adi; Maria Ines Kavamura; Giovanni Neri; Jacqueline Noonan; Elizabeth I Pierpont; Kent Reinker; Amy E Roberts; Suma Shankar; Joseph Sullivan; Melinda Wolford; Brenda Conger; Molly Santa Cruz; Katherine A Rauen
Journal:  Pediatrics       Date:  2014-09-01       Impact factor: 7.124

2.  Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families.

Authors:  Lucy Y Liu; Brett A King; Brittany G Craiglow
Journal:  J Am Acad Dermatol       Date:  2018-02-07       Impact factor: 11.527

Review 3.  The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.

Authors:  Mylène Tajan; Romain Paccoud; Sophie Branka; Thomas Edouard; Armelle Yart
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

4.  Expansion of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Genet Med Rep       Date:  2016-07-01

5.  Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development.

Authors:  Anandaroop Mukhopadhyay; Suguna Rani Krishnaswami; Christopher Cowing-Zitron; Nai-Jung Hung; Heather Reilly-Rhoten; Julianne Burns; Benjamin D Yu
Journal:  Dev Biol       Date:  2012-11-01       Impact factor: 3.582

6.  Elements of morphology: standard terminology for the periorbital region.

Authors:  Bryan D Hall; John M Graham; Suzanne B Cassidy; John M Opitz
Journal:  Am J Med Genet A       Date:  2009-01       Impact factor: 2.802

7.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.

Authors:  Tetsuya Niihori; Yoko Aoki; Yoko Narumi; Giovanni Neri; Hélène Cavé; Alain Verloes; Nobuhiko Okamoto; Raoul C M Hennekam; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Maria Ines Kavamura; Kenji Kurosawa; Hirofumi Ohashi; Louise Wilson; Delphine Heron; Dominique Bonneau; Giuseppina Corona; Tadashi Kaname; Kenji Naritomi; Clarisse Baumann; Naomichi Matsumoto; Kumi Kato; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

Review 8.  The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Opin Genet Dev       Date:  2009-05-19       Impact factor: 5.578

9.  Assessing genotype-phenotype correlation in Costello syndrome using a severity score.

Authors:  Elizabeth M McCormick; Elizabeth Hopkins; Laura Conway; Sarah Catalano; Jobayer Hossain; Katia Sol-Church; Deborah L Stabley; Karen W Gripp
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

Review 10.  EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers.

Authors:  Eszter Doma; Christian Rupp; Manuela Baccarini
Journal:  Int J Mol Sci       Date:  2013-09-25       Impact factor: 5.923

View more
  2 in total

Review 1.  RAS pathway influences the number of melanocytic nevi in cardiofaciocutaneous and Costello syndromes.

Authors:  Maija Kiuru; Jennifer Urban; Guannan Zhu; Iryna Rybak; Jessica R Terrell; Lihong Qi; John D McPherson; Ashfaq A Marghoob; Katherine A Rauen
Journal:  J Am Acad Dermatol       Date:  2020-01-27       Impact factor: 11.527

2.  The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.

Authors:  Maria I Kontaridis; Amy E Roberts; Lisa Schill; Lisa Schoyer; Beth Stronach; Gregor Andelfinger; Yoko Aoki; Marni E Axelrad; Annette Bakker; Anton M Bennett; Alberto Broniscer; Pau Castel; Caitlin A Chang; Lukas Cyganek; Tirtha K Das; Jeroen den Hertog; Emilia Galperin; Shruti Garg; Bruce D Gelb; Kristiana Gordon; Tamar Green; Karen W Gripp; Maxim Itkin; Maija Kiuru; Bruce R Korf; Jeff R Livingstone; Alejandro López-Juárez; Pilar L Magoulas; Sahar Mansour; Theresa Milner; Elisabeth Parker; Elizabeth I Pierpont; Kevin Plouffe; Katherine A Rauen; Suma P Shankar; Shane B Smith; David A Stevenson; Marco Tartaglia; Richard Van; Morgan E Wagner; Stephanie M Ware; Martin Zenker
Journal:  Am J Med Genet A       Date:  2022-03-09       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.